cdk4 6 Search Results


cdk4 6 inhibitor iv  (Santa Cruz Biotechnology)
86
Santa Cruz Biotechnology cdk4 6 inhibitor iv
Cdk4 6 Inhibitor Iv, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cdk4+6/Cdk4%2F6+Inhibitor+IV/pmc04957601-201-23-28
Average 86 stars, based on 1 article reviews
cdk4 6 inhibitor iv - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
serine threonine kinase  (Santa Cruz Biotechnology)
94
Santa Cruz Biotechnology serine threonine kinase
Serine Threonine Kinase, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cdk4+6/CDK+4%2F6+Inhibitor/pm41740233-22-52-134
Average 94 stars, based on 1 article reviews
serine threonine kinase - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier
cdk4/6 inhibitors  (IQVIA Inc)
90
IQVIA Inc cdk4/6 inhibitors
Cdk4/6 Inhibitors, supplied by IQVIA Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cdk4+6/cdk4+6+inhibitors/10__1016_slash_j__annonc__2020__08__408-24-29-24
Average 90 stars, based on 1 article reviews
cdk4/6 inhibitors - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
fcn-437c , cdk4/6 inhibitor fcn-437c in combination with letrozole for hr+/her2-advanced breast cancer  (Fochon Pharma)
90
Fochon Pharma fcn-437c , cdk4/6 inhibitor fcn-437c in combination with letrozole for hr+/her2-advanced breast cancer
The mainly selected biomarkers with putative relevance in CDK4/6-targeted therapies
Fcn 437c , Cdk4/6 Inhibitor Fcn 437c In Combination With Letrozole For Hr+/Her2 Advanced Breast Cancer, supplied by Fochon Pharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cdk4+6/orally+bioavailable+cdk4+6+inhibitor/pmc10331716-43-8-14
Average 90 stars, based on 1 article reviews
fcn-437c , cdk4/6 inhibitor fcn-437c in combination with letrozole for hr+/her2-advanced breast cancer - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
cdk4/6 inhibitor  (MonARC Bionetworks)
90
MonARC Bionetworks cdk4/6 inhibitor
The mainly selected biomarkers with putative relevance in CDK4/6-targeted therapies
Cdk4/6 Inhibitor, supplied by MonARC Bionetworks, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cdk4+6/cdk4+6+inhibitor/pm39875210-92-0-16
Average 90 stars, based on 1 article reviews
cdk4/6 inhibitor - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
cdk4/6 inhibitor palbociclib  (KU Leuven)
90
KU Leuven cdk4/6 inhibitor palbociclib
The mainly selected biomarkers with putative relevance in CDK4/6-targeted therapies
Cdk4/6 Inhibitor Palbociclib, supplied by KU Leuven, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cdk4+6/cdk4+6+inhibitor+palbociclib/pm35784555-7-17-82
Average 90 stars, based on 1 article reviews
cdk4/6 inhibitor palbociclib - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
cdk4-selective inhibitors  (Cyclacel Inc)
90
Cyclacel Inc cdk4-selective inhibitors
The mainly selected biomarkers with putative relevance in CDK4/6-targeted therapies
Cdk4 Selective Inhibitors, supplied by Cyclacel Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cdk4+6/compositions+and+methods+for+predicting+response+and+resistance+to+cdk4+6+inhibition/pmc02864588-52-13-4
Average 90 stars, based on 1 article reviews
cdk4-selective inhibitors - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
endokrinen basierten therapie mit einem cdk4/6-inhibitor  (Anwendung GmbH)
90
Anwendung GmbH endokrinen basierten therapie mit einem cdk4/6-inhibitor
The mainly selected biomarkers with putative relevance in CDK4/6-targeted therapies
Endokrinen Basierten Therapie Mit Einem Cdk4/6 Inhibitor, supplied by Anwendung GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cdk4+6/cdk4+6+inhibitoren/pmc11368471-652-30-18
Average 90 stars, based on 1 article reviews
endokrinen basierten therapie mit einem cdk4/6-inhibitor - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
cdk4/6 inhibitors in combination with xvir-n-31  (XVir Therapeutics GmbH)
90
XVir Therapeutics GmbH cdk4/6 inhibitors in combination with xvir-n-31
The mainly selected biomarkers with putative relevance in CDK4/6-targeted therapies
Cdk4/6 Inhibitors In Combination With Xvir N 31, supplied by XVir Therapeutics GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cdk4+6/cdk4+6+inhibitors+in+combination+with+xvir+n+31/pmc10839048-243-26-5
Average 90 stars, based on 1 article reviews
cdk4/6 inhibitors in combination with xvir-n-31 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
cdk4/6 inhibitor palbociclib  (Absource Diagnostics GmbH)
90
Absource Diagnostics GmbH cdk4/6 inhibitor palbociclib
The mainly selected biomarkers with putative relevance in CDK4/6-targeted therapies
Cdk4/6 Inhibitor Palbociclib, supplied by Absource Diagnostics GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cdk4+6/cdk4+6+inhibitor+palbociclib/bio_rxiv__2024__01__26__577389-237-24-42
Average 90 stars, based on 1 article reviews
cdk4/6 inhibitor palbociclib - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
cdk4/6 inhibitor plus et  (PADMA AG)
90
PADMA AG cdk4/6 inhibitor plus et
The mainly selected biomarkers with putative relevance in CDK4/6-targeted therapies
Cdk4/6 Inhibitor Plus Et, supplied by PADMA AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cdk4+6/cdk4+6+inhibitor+plus+et/pmc05704690-231-7-24
Average 90 stars, based on 1 article reviews
cdk4/6 inhibitor plus et - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
cdk4 reporter construct, wt mbs1–4  (Johns Hopkins HealthCare)
90
Johns Hopkins HealthCare cdk4 reporter construct, wt mbs1–4
The mainly selected biomarkers with putative relevance in CDK4/6-targeted therapies
Cdk4 Reporter Construct, Wt Mbs1–4, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cdk4+6/cdk4+6+cyclin+d+family+members/pmc03351320-36-10-19
Average 90 stars, based on 1 article reviews
cdk4 reporter construct, wt mbs1–4 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


The mainly selected biomarkers with putative relevance in CDK4/6-targeted therapies

Journal: Translational Cancer Research

Article Title: A narrative review about CDK4/6 inhibitors in the setting of drug resistance: updates on biomarkers and therapeutic strategies in breast cancer

doi: 10.21037/tcr-22-2807

Figure Lengend Snippet: The mainly selected biomarkers with putative relevance in CDK4/6-targeted therapies

Article Snippet: FCN-437c , CDK4/6 inhibitor FCN-437c in combination with letrozole for HR+/HER2-advanced breast cancer , Fochon Pharmaceuticals , Drug: FCN-437 , CDK4; CDK6 , Solid tumor, adult , NCT03951116 , May 15, 2019.

Techniques: Histone Deacetylase Assay, Activity Assay, Activation Assay, Expressing, Transformation Assay, Mutagenesis

CDK4/6 inhibitors in active clinical trials

Journal: Translational Cancer Research

Article Title: A narrative review about CDK4/6 inhibitors in the setting of drug resistance: updates on biomarkers and therapeutic strategies in breast cancer

doi: 10.21037/tcr-22-2807

Figure Lengend Snippet: CDK4/6 inhibitors in active clinical trials

Article Snippet: FCN-437c , CDK4/6 inhibitor FCN-437c in combination with letrozole for HR+/HER2-advanced breast cancer , Fochon Pharmaceuticals , Drug: FCN-437 , CDK4; CDK6 , Solid tumor, adult , NCT03951116 , May 15, 2019.

Techniques: